Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 202-436-9 | CAS number: 95-63-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Basic toxicokinetics
Administrative data
- Endpoint:
- basic toxicokinetics in vivo
- Type of information:
- migrated information: read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- supporting study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Non-guideline experimental study with clearly reported methods and results. Adequate for assessment.
Data source
Reference
- Reference Type:
- publication
- Title:
- Excretion of unchanged volatile organic compounds (toluene, ethylbenzene, xylene and mesitylene) in urine as result of experimental human volunteer exposure.
- Author:
- Janasik, B, Jakubowski, M, and Jalowiecki, P
- Year:
- 2 008
- Bibliographic source:
- Int. Arch. Occup. Environ. Health 81: 443-449.
Materials and methods
- Objective of study:
- excretion
Test guideline
- Qualifier:
- no guideline available
- Principles of method if other than guideline:
- The elimination kinetics of unchanged 1,3,5-trimethylbenzene in human urine was examined in six male volunteers exposed by inhalation to 1,3,5-trimethylbenzene. In addition, the relationship between air concentration of 1,3,5-trimethylbenzene and its concentration in urine and blood and the urinary concentration of its metabolite 3,5-dimethylbenzoic acid, was determined.
- GLP compliance:
- not specified
Test material
- Reference substance name:
- Mesitylene
- EC Number:
- 203-604-4
- EC Name:
- Mesitylene
- Cas Number:
- 108-67-8
- Molecular formula:
- C9H12
- IUPAC Name:
- 1,3,5-trimethylbenzene
- Reference substance name:
- 1,3,5-Trimethylbenzene
- IUPAC Name:
- 1,3,5-Trimethylbenzene
- Details on test material:
- - Name of test material (as cited in study report): Mesitylene
- Analytical purity: Not stated.
Constituent 1
Constituent 2
Test animals
- Species:
- human
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- Age of volunteers was between 20 and 28 years.
Administration / exposure
- Route of administration:
- inhalation: vapour
- Vehicle:
- other: air
- Details on exposure:
- TYPE OF INHALATION EXPOSURE: whole body
GENERATION OF TEST ATMOSPHERE / CHAMPER DESCRIPTION
- Exposure apparatus: 117 cubic meter exposure chamber
- Air turnover rate: 350 m3/hr
- System of generating vapours: Vapour generation was based on continuous injection of liquid substance into the pressed air stream, with controlled speed. - Duration and frequency of treatment / exposure:
- A single 4 or 8 hr exposure.
Doses / concentrations
- Remarks:
- Doses / Concentrations:
200 mg/m3 (25 ppm) for the 4-hr study; 20, 60 or 100 mg/m3 (5, 15, or 25 ppm) for the 8-hr study.
- No. of animals per sex per dose / concentration:
- 6 male volunteers
- Control animals:
- no
- Details on dosing and sampling:
- 4-HR EXPOSURE STUDY
Urine samples were collected at the following time points: before exposure, every 2 hr of exposure, and up to 24 hr from the onset of exposure.
8-HR EXPOSURE STUDY
Capillary blood samples obtained from the finger tips were collected before the start of exposure and at 30 min after termination of exposure. Urine samples were collected before exposure and for the last two hours of exposure. - Statistics:
- Statistical analysis was carried out using StatGraphics Plus for Windows 4.1. Linear regression analysis was applied to examine the correlation between exposure parameters.
Results and discussion
Toxicokinetic / pharmacokinetic studies
- Details on excretion:
- The average percentage of the dose excreted as unchanged 1,3,5-trimethylbenzene in urine during the 4-hr exposure period and up to 24 hr post-exposure was 0.0012% (range: 0.00095% to 0.0047%). The elimination kinetics followed an open two-compartment model with half-life values of 0.45 hr and 6.68 hr for the first and second phases, respectively. When 1,3,5-trimethylbenzene was expressed quantitatively in different units, such as urine concentration (uncorrected and corrected for specific gravity or creatinine) and the excretion rate, uncorrected concentration provided the best results.
There was a linear relationship between the air concentration of 1,3,5-trimethylbenzene and the concentration of unchanged substance and its metabolite 3,5-dimethylbenzoic acid in urine samples collected during the last 2 hr of the 8-hr exposure period as well as the concentration of unchanged substance in blood samples collected 30 min after the termination of exposure. Unchanged 1,3,5-trimethylbenzene in urine was found to be a more precise method than the those based on the unchanged substance in blood or its metabolite in urine.
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information): other: Linear relationships were found between the air concentrations of 1,3,5-trimethylbenzene and the concentration of unchanged 1,3,5-trimethylbenzene and its metabolite 3,5-dimethylbenzoic acid as well as the unchanged substance in blood.
Linear relationships were found between the air concentrations of 1,3,5-trimethylbenzene and the concentration of unchanged 1,3,5-trimethylbenzene and its metabolite 3,5-dimethylbenzoic acid in urine as well as the unchanged substance in blood. - Executive summary:
Six male volunteers were exposed to 200 mg/m3 1,3,5 -trimethylbenzene vapours for 4 hours to determine the kinetics of elimination of unchanged 1,3,5 -trimethylbenzene in urine. Urine samples were collected before exposure, every 2 hours of exposure, and up to 24 hours from the start of exposure. In the subsequent study, six male volunteers were exposed to 20, 60, and 100 mg/m3 1,3,5 -trimethylbenzene vapours for 8 hours. Blood samples were collected before exposure and 30 minutes after the end of the exposure. Urine samples were collected before exposure and for the final two hours of the exposure period. The elimination kinetics of 1,3,5 -trimethylbenzene in urine followed an open two-compartment model with the half-life values of 0.45 and 6.68 hours for the first and second phases, respectively. There was a linear relationship between the air concentration of 1,3,5-trimethylbenzene and the concentration of unchanged substance and its metabolite 3,5-dimethylbenzoic acid in urine as well as the unchanged substance in blood. Unchanged 1,3,5-trimethylbenzene in urine was found to be a more precise method than those based on the unchanged substance in blood or its metabolite in urine.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.